title: Does maternal use of tenofovir during pregnancy affect growth of HIV-exposed uninfected infants?
authors.forename: Louise
authors.initials: L
authors.lastname: Kuhn
authors.forename: Marc
authors.initials: M
authors.lastname: Bulterys
mesh_terms: D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives*; D019380:Anti-HIV Agents / Q000009:adverse effects*; D049628:Body Size / Q000187:drug effects*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007231:Infant, Newborn / Q000254:growth & development*; D008297:Male; D063065:Organophosphonates / Q000009:adverse effects*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D000068698:Tenofovir
chemical_list: D019380:Anti-HIV Agents; D063065:Organophosphonates; D000068698:Tenofovir; D000225:Adenine